NCT04787653View on ClinicalTrials.gov

Evaluation of the OtoBand as a Treatment to Reduce the Perceived Loudness of Tinnitus

NAUnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 5, 2021

Primary Completion Date

January 31, 2024

Study Completion Date

February 28, 2024

Conditions
Tinnitus
Interventions
DEVICE

Otoband

Participants with Tinnitus will wear the Otoband set at an effective power level during a 30 minute time frame and outcome measurements will be recorded in a Google Form.

DEVICE

Placebo

Participants with Tinnitus will wear the Otoband set at a non-effective power level during a 30 minute time frame and outcome measurements will be recorded in a Google Form.

Trial Locations (1)

20009

OtolithLabs https://otolithlabs.com/tinnitustelehealthstudy/, Washington D.C.

Sponsors

Lead Sponsor

Otolith Labs
All Listed Sponsors
lead

Otolith Labs

INDUSTRY

NCT04787653 - Evaluation of the OtoBand as a Treatment to Reduce the Perceived Loudness of Tinnitus | Biotech Hunter | Biotech Hunter